Asia-Pacific Oligonucleotide Synthesis Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Oligonucleotide Synthesis Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Primers Market Performance (Volume)
  • 2.1.2 Probes Market Performance (Volume)
  • 2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Volume)
  • 2.1.4 Large-scale Synthesis Oligos Market Performance (Volume)
  • 2.1.5 Linkers and Adaptors Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Primers Market Performance (Value)
  • 2.1.2 Probes Market Performance (Value)
  • 2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Value)
  • 2.1.4 Large-scale Synthesis Oligos Market Performance (Value)
  • 2.1.5 Linkers and Adaptors Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Commercial Market Performance (Volume)
  • 3.1.2 Academic Research Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Genescript
  • 4.1.1 Genescript Profiles
  • 4.1.2 Genescript Product Information
  • 4.1.3 Genescript Oligonucleotide Synthesis Business Performance
  • 4.1.4 Genescript Oligonucleotide Synthesis Business Development and Market Status
• 4.2 GeneArt (Thermofischer)
  • 4.2.1 GeneArt (Thermofischer) Profiles
  • 4.2.2 GeneArt (Thermofischer) Product Information
  • 4.2.3 GeneArt (Thermofischer) Oligonucleotide Synthesis Business Performance
  • 4.2.4 GeneArt (Thermofischer) Oligonucleotide Synthesis Business Development and Market Status
• 4.3 IDT
  • 4.3.1 IDT Profiles
  • 4.3.2 IDT Product Information
  • 4.3.3 IDT Oligonucleotide Synthesis Business Performance
  • 4.3.4 IDT Oligonucleotide Synthesis Business Development and Market Status
• 4.4 DNA 2.0 (ATUM)
  • 4.4.1 DNA 2.0 (ATUM) Profiles
  • 4.4.2 DNA 2.0 (ATUM) Product Information
  • 4.4.3 DNA 2.0 (ATUM) Oligonucleotide Synthesis Business Performance
  • 4.4.4 DNA 2.0 (ATUM) Oligonucleotide Synthesis Business Development and Market Status
• 4.5 OriGene
  • 4.5.1 OriGene Profiles
  • 4.5.2 OriGene Product Information
  • 4.5.3 OriGene Oligonucleotide Synthesis Business Performance
  • 4.5.4 OriGene Oligonucleotide Synthesis Business Development and Market Status
• 4.6 BBI
  • 4.6.1 BBI Profiles
  • 4.6.2 BBI Product Information
  • 4.6.3 BBI Oligonucleotide Synthesis Business Performance
  • 4.6.4 BBI Oligonucleotide Synthesis Business Development and Market Status
• 4.7 Genewiz
  • 4.7.1 Genewiz Profiles
  • 4.7.2 Genewiz Product Information
  • 4.7.3 Genewiz Oligonucleotide Synthesis Business Performance
  • 4.7.4 Genewiz Oligonucleotide Synthesis Business Development and Market Status
• 4.8 Eurofins Genomics
  • 4.8.1 Eurofins Genomics Profiles
  • 4.8.2 Eurofins Genomics Product Information
  • 4.8.3 Eurofins Genomics Oligonucleotide Synthesis Business Performance
  • 4.8.4 Eurofins Genomics Oligonucleotide Synthesis Business Development and Market Status
• 4.9 Gene Oracle
  • 4.9.1 Gene Oracle Profiles
  • 4.9.2 Gene Oracle Product Information
  • 4.9.3 Gene Oracle Oligonucleotide Synthesis Business Performance
  • 4.9.4 Gene Oracle Oligonucleotide Synthesis Business Development and Market Status
• 4.10 SBS Genetech
  • 4.10.1 SBS Genetech Profiles
  • 4.10.2 SBS Genetech Product Information
  • 4.10.3 SBS Genetech Oligonucleotide Synthesis Business Performance
  • 4.10.4 SBS Genetech Oligonucleotide Synthesis Business Development and Market Status
• 4.11 Bio Basic

5 Market Performance for Manufacturers

• 5.1 Asia-Pacific Oligonucleotide Synthesis Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Asia-Pacific Oligonucleotide Synthesis Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Asia-Pacific Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Asia-Pacific Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Oligonucleotide Synthesis Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Oligonucleotide Synthesis Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Japan Market Performance for Manufacturers
  • 6.2.1 Japan Oligonucleotide Synthesis Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Japan Oligonucleotide Synthesis Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Japan Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Japan Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Korea Market Performance for Manufacturers
  • 6.3.1 South Korea Oligonucleotide Synthesis Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Korea Oligonucleotide Synthesis Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Korea Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Korea Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Taiwan Market Performance for Manufacturers
  • 6.4.1 Taiwan Oligonucleotide Synthesis Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Taiwan Oligonucleotide Synthesis Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Taiwan Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Taiwan Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 India Market Performance for Manufacturers
  • 6.5.1 India Oligonucleotide Synthesis Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 India Oligonucleotide Synthesis Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 India Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 India Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Southeast Asia Market Performance for Manufacturers
  • 6.6.1 Southeast Asia Oligonucleotide Synthesis Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Southeast Asia Oligonucleotide Synthesis Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Southeast Asia Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Southeast Asia Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Australia Market Performance for Manufacturers
  • 6.7.1 Australia Oligonucleotide Synthesis Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Australia Oligonucleotide Synthesis Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Australia Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Australia Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Oligonucleotide Synthesis Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Oligonucleotide Synthesis Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Oligonucleotide Synthesis Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Oligonucleotide Synthesis Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Asia-Pacific Oligonucleotide Synthesis Market Performance (Sales Point)

• 7.1 Asia-Pacific Oligonucleotide Synthesis Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Asia-Pacific Oligonucleotide Synthesis Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Asia-Pacific Oligonucleotide Synthesis Price (USD/Unit) by Regions 2013-2018
• 7.4 Asia-Pacific Oligonucleotide Synthesis Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Asia-Pacific Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Japan Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Korea Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Taiwan Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 India Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Southeast Asia Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Oligonucleotide Synthesis Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Commercial Industry
• 11.2 Academic Research Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Asia-Pacific Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Asia-Pacific Oligonucleotide Synthesis Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Japan Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Korea Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Taiwan Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 India Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Southeast Asia Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Australia Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Oligonucleotide Synthesis Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Primers Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Probes Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Intermediate-scale Synthesis Oligos Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.5 Large-scale Synthesis Oligos Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Commercial Sales and and Growth Rate 2019-2024
  • 12.4.3 Academic Research Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Asia-Pacific Oligonucleotide Synthesis Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Asia-Pacific Oligonucleotide Synthesis Gross Profit Trend 2019-2024

13 Conclusion